Drugs that contain Avibactam Sodium; Ceftazidime

1. List of Avycaz drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7112592 ALLERGAN Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents
Jan, 2026

(2 years from now)

US8471025 ALLERGAN Crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium salt
Aug, 2031

(8 years from now)

US9695122 ALLERGAN Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof
Jun, 2032

(9 years from now)

US9284314 ALLERGAN Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof
Jun, 2032

(9 years from now)

US8969566 ALLERGAN Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof
Jun, 2032

(9 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7612087 ALLERGAN Heterocyclic compounds as inhibitors of beta-lactamases
Nov, 2026

(3 years from now)

US8835455 ALLERGAN Crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium salt
Oct, 2030

(7 years from now)

Exclusivity Exclusivity Expiration
New Chemical Entity Exclusivity (NCE) Feb 25, 2020
Generating Antibiotic Incentives Now (GAIN) Feb 25, 2025

NCE-1 date: February, 2024

Market Authorisation Date: 25 February, 2015

Treatment: A method of treating bacterial infections in complicated intra-abdominal infection and complicated urinary tract infection, including pyelonephritis, patients comprising administering a bactericidally effective amount of avibactam sodium; A method of treating bacterial infections in hospital-acquired bacterial pneumonia and ventilator-associated bacterial pnenumonia (habp/vabp) patients comprising administering a bactericidally effective amount of avibactam sodium; Method of treating bacterial infections

Dosage: POWDER;INTRAVENOUS

More Information on Dosage

AVYCAZ family patents

22

United States

9

Japan

9

China

8

European Union

7

Korea, Republic of

7

Brazil

6

Spain

5

Hong Kong

5

Australia

5

Israel

5

France

4

Poland

4

Mexico

4

Slovenia

4

Argentina

4

Portugal

4

Russia

4

Canada

4

Denmark

3

Malaysia

3

Cyprus

3

Hungary

3

Norway

3

Taiwan, Province of China

3

Costa Rica

2

Austria

2

Morocco

2

Ukraine

2

Yugoslavia

2

Germany

2

OA

2

South Africa

2

Croatia

2

EA

2

Turkey

2

ME

2

New Zealand

2

Ecuador

1

Estonia

1

AP

1

Chile

1

Algeria

1

Lithuania

1

Slovakia

1

Uruguay

1

Jordan

1

Netherlands

1

Tunisia

1

United Kingdom

1

Colombia

1

Belgium

1

Peru

1

Bulgaria

1

Singapore

1

Czech Republic

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in